Research and Markets (http://www.researchandmarkets.com/research/th6m2l/global_depression) has announced the addition of the "Global Depression Epidemiology and Patient Flow Analysis - 2015" report to their offering.
This report provides insights into Depression epidemiology, Depression diagnosed patients, and Depression treatment rate for the top seven pharmaceutical markets. The study measures key indicators such as prevalence of Depression derived from epidemiological analysis, percentage of patients diagnosed with Depression, and percentage of patients treated with Depression therapy.
The study helps executives estimate Depression market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Depression prevalence, Depression diagnosis rate, and Depression treatment rate for the period 2014 - 2020. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.
Key Topics Covered:
1. Depression: Disease Definition
2. Global Depression Patient Flow
3. Depression Patient Flow in the US
4. Depression Patient Flow in Europe
5. Depression Patient Flow in Germany
6. Depression Patient Flow in France
7. Depression Patient Flow in Spain
8. Depression Patient Flow in Italy
9. Depression Patient Flow in UK
10. Depression Patient Flow in Japan
11. Appendix
For more information visit http://www.researchandmarkets.com/research/th6m2l/global_depression.
